Published in Hepatology on November 01, 1998
Liver regeneration. J Cell Physiol (2007) 6.69
Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol (2009) 3.55
Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol (2006) 1.84
Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chem Res Toxicol (2009) 1.70
Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med (2000) 1.68
An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol (2009) 1.54
Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice. Proc Natl Acad Sci U S A (2002) 1.51
RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB. J Exp Med (2005) 1.35
A fresh look at augmenter of liver regeneration in rats. Hepatology (1999) 1.32
An inducible autocrine cascade regulates rat hepatocyte proliferation and apoptosis responses to tumor necrosis factor-alpha. Hepatology (2008) 1.30
Mitogenic properties of endogenous and pharmacological doses of macrophage inflammatory protein-2 after 70% hepatectomy in the mouse. Am J Pathol (2003) 1.21
Cell cycle effects resulting from inhibition of hepatocyte growth factor and its receptor c-Met in regenerating rat livers by RNA interference. Hepatology (2007) 1.20
Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes. J Virol (2003) 1.11
Gene deletions and amplifications in human hepatocellular carcinomas: correlation with hepatocyte growth regulation. Am J Pathol (2012) 1.10
Stem cell factor restores hepatocyte proliferation in IL-6 knockout mice following 70% hepatectomy. J Clin Invest (2003) 1.09
CXC chemokine signaling in the liver: impact on repair and regeneration. Hepatology (2011) 1.07
Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia. J Cell Mol Med (2009) 1.07
Antitumor immunity produced by the liver Kupffer cells, NK cells, NKT cells, and CD8 CD122 T cells. Clin Dev Immunol (2011) 1.02
A complement-IL-4 regulatory circuit controls liver regeneration. J Immunol (2011) 0.99
Liver regeneration, growth factors, and amphiregulin. Gastroenterology (2005) 0.97
A model of liver regeneration. Biophys J (2009) 0.95
A critical appraisal of the hemodynamic signal driving liver regeneration. Langenbecks Arch Surg (2012) 0.94
Signals and cells involved in regulating liver regeneration. Cells (2012) 0.94
Toll-like receptor 4 and myeloid differentiation factor 88 provide mechanistic insights into the cause and effects of interleukin-6 activation in mouse liver regeneration. Hepatology (2011) 0.94
HMG box transcriptional repressor HBP1 maintains a proliferation barrier in differentiated liver tissue. Mol Cell Biol (2001) 0.94
Inhibition of DNA synthesis in cultured hepatocytes by endotoxin-conditioned medium of activated stellate cells is transforming growth factor-beta and nitric oxide-independent. Br J Pharmacol (2001) 0.93
Transcriptional activation by growth hormone of HNF-6-regulated hepatic genes, a potential mechanism for improved liver repair during biliary injury in mice. Am J Physiol Gastrointest Liver Physiol (2008) 0.93
Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosamine in rats. Am J Pathol (2007) 0.90
Mechanism in the sequential control of cell morphology and S phase entry by epidermal growth factor involves distinct MEK/ERK activations. Mol Biol Cell (2001) 0.90
A nanoconjugate Apaf-1 inhibitor protects mesothelial cells from cytokine-induced injury. PLoS One (2009) 0.89
NEDD4 controls the expression of GUCD1, a protein upregulated in proliferating liver cells. Cell Cycle (2014) 0.89
Tumor necrosis factor-alpha acts as a complete mitogen for primary rat hepatocytes. Am J Pathol (2003) 0.89
Impact of rapamycin on liver regeneration. Virchows Arch (2008) 0.87
Cholera toxin-sensitive GTP-binding protein-coupled activation of augmenter of liver regeneration (ALR) receptor and its function in rat kupffer cells. J Cell Physiol (2010) 0.85
Proteomic analysis of regenerating mouse liver following 50% partial hepatectomy. Proteome Sci (2009) 0.84
The mitogenic activity of hepatocyte growth factor on rat hepatocytes is dependent upon endogenous transforming growth factor-alpha. Am J Pathol (2000) 0.84
Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure. World J Gastroenterol (2013) 0.82
Expression of tumor necrosis factor-alpha converting enzyme in liver regeneration after partial hepatectomy. World J Gastroenterol (2008) 0.81
Mouse CD11b+Kupffer Cells Recruited from Bone Marrow Accelerate Liver Regeneration after Partial Hepatectomy. PLoS One (2015) 0.80
Nitric oxide inhibits HIV tat-induced NF-kappaB activation. Am J Pathol (1999) 0.80
Regulation of the g1/s transition in hepatocytes: involvement of the cyclin-dependent kinase cdk1 in the DNA replication. Int J Hepatol (2012) 0.79
P2Y2 purinergic receptor activation is essential for efficient hepatocyte proliferation in response to partial hepatectomy. Am J Physiol Gastrointest Liver Physiol (2014) 0.78
A disintegrin and metalloproteinase 17 regulates TNF and TNFR1 levels in inflammation and liver regeneration in mice. Am J Physiol Gastrointest Liver Physiol (2013) 0.78
Moderate (2%, v/v) Ethanol Feeding Alters Hepatic Wound Healing after Acute Carbon Tetrachloride Exposure in Mice. Biomolecules (2016) 0.78
Blockade of the apelin-APJ system promotes mouse liver regeneration by activating Kupffer cells after partial hepatectomy. J Gastroenterol (2014) 0.78
Defective Initiation of Liver Regeneration in Osteopontin-Deficient Mice after Partial Hepatectomy due to Insufficient Activation of IL-6/Stat3 Pathway. Int J Biol Sci (2015) 0.78
Regulatory mechanisms of injury and repair after hepatic ischemia/reperfusion. Scientifica (Cairo) (2012) 0.77
Pentoxifylline improves liver regeneration through down-regulation of TNF-α synthesis and TGF-β1 gene expression. World J Gastrointest Surg (2012) 0.77
Combined Stimulation with the Tumor Necrosis Factor α and the Epidermal Growth Factor Promotes the Proliferation of Hepatocytes in Rat Liver Cultured Slices. Int J Hepatol (2012) 0.77
Combined systemic elimination of MET and epidermal growth factor receptor signaling completely abolishes liver regeneration and leads to liver decompensation. Hepatology (2016) 0.77
Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantation. World J Gastroenterol (2007) 0.77
Remote ischemic preconditioning prevents lipopolysaccharide-induced liver injury through inhibition of NF-κB activation in mice. J Anesth (2014) 0.77
Transcriptomic characterization of the dorsal lobes after hepatectomy of the ventral lobe in zebrafish. BMC Genomics (2015) 0.75
Retinoic Acid-mediated Nuclear Receptor Activation and Hepatocyte Proliferation. J Exp Clin Med (2009) 0.75
Ischaemic Preconditioning and Intermittent Clamping Does not Influence Mediators of Liver Regeneration in a Human Liver Sinusoidal Endothelial Cell Model of Ischaemia-Reperfusion Injury. Gastroenterology Res (2012) 0.75
C57BL/6 substrains exhibit different responses to acute carbon tetrachloride exposure: Implications for work involving transgenic mice. Gene Expr (2017) 0.75
Mechanistic Modelling of Drug-Induced Liver Injury: Investigating the Role of Innate Immune Responses. Gene Regul Syst Bio (2017) 0.75
Perioperative hepatocyte growth factor (HGF) infusions improve hepatic regeneration following portal branch ligation (PBL) in rodents. Surg Endosc (2016) 0.75
Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis (1999) 12.31
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology (2001) 6.88
Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology (1999) 5.70
Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology (1999) 5.64
Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A (1997) 4.33
TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell (1990) 3.86
Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med (1991) 3.14
Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci U S A (1988) 2.62
Cell lineages and oval cell progenitors in rat liver development. Cancer Res (1991) 2.62
NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J Cell Biol (1998) 2.49
Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients. Gastroenterology (1995) 2.47
Ornithine decarboxylase activity and the onset of deoxyribonucleic acid synthesis in regenerating liver. Biochem J (1978) 2.35
Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci U S A (1989) 2.35
Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages. Proc Natl Acad Sci U S A (2006) 2.32
Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D-galactosamine. Am J Pathol (1991) 2.31
Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proc Natl Acad Sci U S A (1994) 2.20
Red tide (Ptychodiscus brevis) toxin aerosols: a review. Toxicon (1986) 2.04
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat (2011) 2.00
Regulated transcription of c-Ki-ras and c-myc during compensatory growth of rat liver. Mol Cell Biol (1984) 1.98
Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology (1993) 1.97
Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis. Hepatology (1989) 1.97
Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology (1998) 1.96
Expression of a cellular oncogene during liver regeneration. Science (1983) 1.88
Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology (1998) 1.83
Toward a better liver graft allocation that accounts for candidates with and without hepatocellular carcinoma. Am J Transplant (2014) 1.77
Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration. Cell Growth Differ (1995) 1.75
Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg (1996) 1.73
Expression of suppressors of cytokine signaling during liver regeneration. J Clin Invest (2001) 1.71
Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med (2000) 1.68
Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology (1983) 1.67
Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene (2003) 1.63
Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective. Hepatology (2001) 1.53
World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective. J Gastrointestin Liver Dis (2010) 1.52
Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology (1990) 1.52
Isolation of oval cells by centrifugal elutriation and comparison with other cell types purified from normal and preneoplastic livers. Cancer Res (1984) 1.52
Prevention of hepatic apoptosis and embryonic lethality in RelA/TNFR-1 double knockout mice. Am J Pathol (2000) 1.46
Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am J Pathol (1998) 1.45
Sequential protooncogene expression during rat liver regeneration. Cancer Res (1986) 1.42
Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology (1992) 1.42
Generation of hepatocytes from oval cell precursors in culture. Cancer Res (1998) 1.41
In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology (1994) 1.38
Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor kappaB activation. Cell Growth Differ (1999) 1.37
Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation. J Nucl Med (1988) 1.37
Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines. Cell Growth Differ (1997) 1.36
Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage. Hepatology (1984) 1.36
Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy. Hepatology (2000) 1.35
The control of ornithine decarboxylase activity during liver regeneration. Biochim Biophys Acta (1971) 1.32
Isozyme profiles of oval cells, parenchymal cells, and biliary cells isolated by centrifugal elutriation from normal and preneoplastic livers. Cancer Res (1984) 1.32
Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut (2002) 1.29
Transforming growth factor-beta (TGF-beta) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-beta. Cell Regul (1991) 1.27
c-myc, c-fos, and c-jun regulation in the regenerating livers of normal and H-2K/c-myc transgenic mice. Mol Cell Biol (1990) 1.27
Cell lineages in liver carcinogenesis: possible clues from studies of the distribution of alpha-fetoprotein RNA sequences in cell populations isolated from normal, regenerating, and preneoplastic rat livers. Cancer Res (1985) 1.25
Expression of c-Ki-ras, c-Ha-ras, and c-myc in specific cell types during hepatocarcinogenesis. Mol Cell Biol (1985) 1.22
Fine-needle aspiration biopsy of portal vein thrombus: value in detecting malignant thrombosis. AJR Am J Roentgenol (1993) 1.21
Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases. Clin Chem (1991) 1.20
Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol (1997) 1.19
Detection of changes in mitochondrial function during apoptosis by simultaneous staining with multiple fluorescent dyes and correlated multiparameter flow cytometry. Cytometry (1999) 1.19
Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes. Am J Pathol (1997) 1.18
Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo. Proc Natl Acad Sci U S A (1995) 1.18
What's in a Name? The American Society for Investigative Pathology. Am J Pathol (1993) 1.15
Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha. Cancer Res (2001) 1.14
Production of hepatocellular carcinoma by oval cells: cell cycle expression of c-myc and p53 at different stages of oval cell transformation. Cancer Res (1989) 1.13
Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats. Cancer Res (1987) 1.13
Prospective validation of the Cancer of the Liver Italian Program (CLIP) score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology (2000) 1.13
Overexpression of transforming growth factor-alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am J Pathol (1994) 1.13
Studies on ornithine decarboxylase activity in normal and regenerating livers. Biochim Biophys Acta (1969) 1.12
c-met mRNA overexpression in human hepatocellular carcinoma. Hepatology (1994) 1.11
Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1. Cancer Res (1994) 1.11
Development of liver tumors in transforming growth factor alpha transgenic mice. Cancer Res (1992) 1.10
Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma. Hepatology (2000) 1.10
Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis. Hepatology (1985) 1.09
Disruption of redox homeostasis in tumor necrosis factor-induced apoptosis in a murine hepatocyte cell line. Am J Pathol (2000) 1.09
Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever. J Hepatol (1995) 1.05
Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice. Cancer Res (1992) 1.05
A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis. Br J Cancer (2013) 1.05
Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases. J Hepatol (1990) 1.05
Enhanced acetaminophen hepatotoxicity in transgenic mice overexpressing BCL-2. Mol Pharmacol (2001) 1.05
Persistence and biodegradation of spilled residual fuel oil on an estuarine beach. Appl Microbiol (1975) 1.03
Expression of Bcl-2 family during liver regeneration and identification of Bcl-x as a delayed early response gene. Am J Pathol (1997) 1.03
Induction of replicative competence ("priming") in normal liver. Cancer Res (1990) 1.03
alpha-Fetoprotein and albumin mRNA levels in liver regeneration and carcinogenesis. J Biol Chem (1983) 1.02
Oncogene expression in liver regeneration and hepatocarcinogenesis. Hepatology (1983) 1.02
Gene expression of endothelin-1 and ET(A) and ET(B) receptors in human cirrhosis: relationship with hepatic hemodynamics. J Vasc Res (1998) 1.01
Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. J Hepatol (1998) 0.99
Multiple alpha-fetoprotein RNAs in adult rat liver: cell type-specific expression and differential regulation. Cancer Res (1991) 0.99
Expression of hepatocyte and oval cell antigens in hepatocellular carcinomas produced by oncogene-transfected liver epithelial cells. Cancer Res (1990) 0.98
High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis. Hepatology (2001) 0.97
Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol (2006) 0.97
Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage. Gastroenterology (1989) 0.96
Serum levels of C-erbB-2 (HER-2/neu) in patients with malignant and non-malignant diseases. Tumour Biol (1997) 0.96
Transforming growth factor receptors in liver regeneration following partial hepatectomy in the rat. Cancer Res (1990) 0.95
Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver. Gastroenterology (1985) 0.94
Internal mammary silicone lymphadenopathy mimicking recurrent breast cancer. Plast Reconstr Surg (1997) 0.94
Ornithine decarboxylase activity and polyamine synthesis during kidney hypertrophy. Biochim Biophys Acta (1972) 0.93
"Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients? Am J Transplant (2014) 0.92
Gene expression and the diversity of polysomal messenger RNA sequences in regenerating liver. J Biol Chem (1980) 0.90
Protection of human and murine hepatocytes against Fas-induced death by transferrin and iron. Apoptosis (2006) 0.90